BR0212625A - peptìdeos derivados de caseìna e usos dos mesmos em terapia - Google Patents
peptìdeos derivados de caseìna e usos dos mesmos em terapiaInfo
- Publication number
- BR0212625A BR0212625A BRPI0212625-7A BR0212625A BR0212625A BR 0212625 A BR0212625 A BR 0212625A BR 0212625 A BR0212625 A BR 0212625A BR 0212625 A BR0212625 A BR 0212625A
- Authority
- BR
- Brazil
- Prior art keywords
- casein
- derived
- peptides
- therapy
- derived peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/942,121 US20020147144A1 (en) | 2000-03-01 | 2001-08-30 | Casein derived peptides and uses thereof in therapy |
PCT/IL2002/000720 WO2003018606A2 (fr) | 2001-08-30 | 2002-08-29 | Peptides derives de la caseine et leurs utilisations therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212625A true BR0212625A (pt) | 2007-06-19 |
Family
ID=25477603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0212625-7A BR0212625A (pt) | 2001-08-30 | 2002-08-29 | peptìdeos derivados de caseìna e usos dos mesmos em terapia |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1556074A4 (fr) |
JP (1) | JP2005511499A (fr) |
KR (1) | KR20040078639A (fr) |
CN (1) | CN1694719A (fr) |
AU (1) | AU2002324323A2 (fr) |
BR (1) | BR0212625A (fr) |
CA (1) | CA2458924A1 (fr) |
CZ (1) | CZ2004335A3 (fr) |
HU (1) | HUP0500995A3 (fr) |
IL (1) | IL160548A0 (fr) |
MX (1) | MXPA04001890A (fr) |
NO (1) | NO20040880L (fr) |
PL (1) | PL375113A1 (fr) |
WO (1) | WO2003018606A2 (fr) |
ZA (1) | ZA200401574B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
AU2005209845A1 (en) * | 2004-01-30 | 2005-08-18 | Chemgenex Pharmaceuticals, Inc. | Naphthalimide dosing by N-acetyl transferase genotyping |
MXPA06010014A (es) * | 2004-03-01 | 2007-03-07 | Peptera Pharmaceuticals Ltd | Peptidos derivados de la caseina y usos terapeuticos de los mismos. |
GB0423352D0 (en) | 2004-10-21 | 2004-11-24 | Hannah Res Inst | "Control of mammary cell number" |
ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
US8921310B2 (en) | 2006-06-09 | 2014-12-30 | Morinaga Milk Industry Co., Ltd. | Method for accelerating mammalian body fat metabolism |
JP2011026213A (ja) * | 2009-07-22 | 2011-02-10 | Snow Brand Milk Prod Co Ltd | 1型糖尿病抑制ペプチド |
CA2870537A1 (fr) * | 2012-04-16 | 2013-10-24 | The Cleveland Clinic Foundation | Vaccin multivalent contre le cancer du sein |
WO2018159546A1 (fr) * | 2017-03-03 | 2018-09-07 | 森永乳業株式会社 | Sécrétagogue de glp -1 et composition |
CN107814835B (zh) * | 2017-12-01 | 2020-04-28 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽avpitptlnreq及其制备方法和应用 |
CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
CN113952446B (zh) * | 2021-09-03 | 2023-12-05 | 河南省医药科学研究院 | 生物活性肽在抑制骨髓毒性中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
EP0922769A4 (fr) * | 1997-03-21 | 2000-07-12 | Snow Brand Milk Products Co Ltd | Hydrolysat du complexe fer-caseine et son procede de production |
IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
-
2002
- 2002-08-29 CA CA002458924A patent/CA2458924A1/fr not_active Abandoned
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/fr active Search and Examination
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 EP EP02758768A patent/EP1556074A4/fr not_active Withdrawn
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Application Discontinuation
-
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005511499A (ja) | 2005-04-28 |
KR20040078639A (ko) | 2004-09-10 |
CA2458924A1 (fr) | 2003-03-06 |
EP1556074A4 (fr) | 2008-05-07 |
WO2003018606A3 (fr) | 2005-05-06 |
AU2002324323A2 (en) | 2003-03-10 |
WO2003018606A9 (fr) | 2004-04-08 |
MXPA04001890A (es) | 2004-06-18 |
CZ2004335A3 (cs) | 2004-07-14 |
HUP0500995A2 (en) | 2007-05-02 |
IL160548A0 (en) | 2004-07-25 |
WO2003018606A2 (fr) | 2003-03-06 |
PL375113A1 (en) | 2005-11-28 |
EP1556074A2 (fr) | 2005-07-27 |
HUP0500995A3 (en) | 2008-09-29 |
NO20040880L (no) | 2004-04-20 |
ZA200401574B (en) | 2007-02-28 |
CN1694719A (zh) | 2005-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109027A (pt) | Peptìdios derivados de caseìna e usos dos mesmos em terapia | |
EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
BR0212625A (pt) | peptìdeos derivados de caseìna e usos dos mesmos em terapia | |
HK1014191A1 (en) | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof | |
CA2181150A1 (fr) | Peptides bioroniquement actifs provenant de domaines fonctionnels d'une proteine bactericide augmentant la permeabilite, et leurs utilisations | |
DE69841982D1 (de) | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie | |
BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
MY129566A (en) | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance | |
DE60213648D1 (de) | Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln | |
DE60024100D1 (de) | Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen | |
BR9808100A (pt) | Utilização de amandantina para tratamento de hepatite c. | |
DK1429800T3 (da) | Vaccine og anvendelse deraf til behandling af amyotrofisk lateral sklerose | |
FR2870126A1 (fr) | Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin | |
BR112022024074A2 (pt) | Coquetel de peptídeos | |
FI971275A (fi) | Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset | |
BR9809457A (pt) | Sais de peptìdeo de bpc com atividade organo-protetora, o processo para sua preparação e seu uso em terapia. | |
IT1294967B1 (it) | Composizione immunogenica da tlp | |
HUP9901299A2 (hu) | Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi | |
IT1283899B1 (it) | Peptidi e loro usi nella terapia della malattia celiaca | |
JP2001172190A5 (fr) | ||
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
ATE386542T1 (de) | Mittel zur stimulation des immunsystems | |
JP2001172189A5 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011. |